Pharmaceutical Technology4h
Aclaris Therapeutics secures global rights to Biosion’s antibodies
Aclaris Therapeutics has secured an exclusive license from Biosion for the global rights to two new antibodies.
Reader's Digest Canada on MSN4d
30 Old-Time Home Remedies That Actually Work
Honey to heal a wound. Cherries for gout. Cod-liver oil— blech!—to keep your eyes healthy. Your grandmother and her doctors ...
Too Old to Operate4d
Safety Profile of Oral JAK Inhibitors in AD Treatment
The following is a summary of “Comparative safety of oral Janus kinase inhibitors versus dupilumab in patients with atopic ...
InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today announced that the first subject has been dosed in ...
Organon: 7% Yield, 4x P/E, Big Upside Potential
Organon is a strong investment opportunity with a high yield, diversified portfolio, steady performance, and transformative ...
Taiwan News5d
Arcutis’ ZORYVE® (roflumilast) Awarded Best Eczema Treatment by Glamour
ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic dermatitis ZORYVE, a next-generation topical phosphodiesterase-4 ...
Enveda Announces First Candidate Discovered From Nature Using AI Advances to Clinical Trials
Enveda, a biotechnology company using AI to translate nature into new medicines, announced today that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) ...